Intracavernosal Needle breakage developed during Self-injection of Vasoactive Agent : Two case reports / 대한남성과학회지

Currently intracavernous pharmacotherapy is the second common therapeutic modality for erectile dysfunction after the introduction of Viagra. Nevertheless, intracavernous pharmacotherapy has increased in popularity for the past 15 years. While having an overwhelming safety after complete training in injection method, this treatment option can reveal unexpected complications related to self-injection. We report two cases of intracavernous needle breakage associated with alprostadil (Caverject , Pharmacia-Upjohn) and trimix self-injection therapy with a brief review of the literature.

A Case of Intracavernous Needle Breakage during Intracavernous Self-injection of Prostaglandin E1 ( Caverject? ) / 대한비뇨기과학회지

Intracavernous self-injection of vasoactive agents for the treatment of erectile dysfunction has been used widespread in recent years. Complications of intracavernous self-injection include priapism, burning sensation, fibrosis, penile nodule and urethral injection. We report a case of intracavernous needle breakage associated with the Prostaglandin E1 self-injection therapy.